thioridazine has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, Q; Huang, W; Li, M; Liu, Y; Lu, J; Mu, J; Tan, Z; Wu, X; Xiao, J; Xu, H; Yang, Y; Zhang, L | 1 |
1 other study(ies) available for thioridazine and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
| Article | Year |
|---|---|
Thioridazine, an antipsychotic drug, elicits potent antitumor effects in gastric cancer.
Topics: Amino Acid Chloromethyl Ketones; Animals; Antineoplastic Agents; Antipsychotic Agents; Apoptosis; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Proliferation; Humans; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Stomach Neoplasms; Thioridazine | 2014 |